IMPROVEMENT IN EXPIRATORY FLOWRATE IN ASTHMATICS NEBULIZED IN SITTING VS LYING DOWN-POSITION: A COMPARATIVE STUDY

M ZAHID; A SAEED; SA RAUF; S KHAN

doi:10.54112/bcsrj.v2024i1.965

Authors

M ZAHID Department of Internal Medicine, CMH Lahore, Pakistan
A SAEED Department of Internal Medicine, CMH Lahore, Pakistan
SA RAUF Department of Internal Medicine, CMH Lahore, Pakistan
S KHAN Federal Medical College/ Pakistan Institute of Medical Sciences (PIMS), Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.965

Keywords:

Asthma, Bronchodilator, Expiratory Flow Rate, Nebulization, Posture

Abstract

Asthma, a chronic inflammatory disorder of the airways, is characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Objectives: The main objective of the study is to find the improvement in expiratory flowrate in asthmatics nebulized in sitting vs lying down-position. Methods: This comparative study was conducted at CMH, Lahore during May 2023 to May 2024 and data were collected from 245 patients. Each participant received a standardized dose of a bronchodilator via a nebulizer. In the sitting position group, patients were instructed to sit upright in a comfortable chair with back support. In the lying down position group, patients were instructed to lie supine on a flat surface. Both groups received the nebulized medication for the same duration, and all procedures were conducted in a controlled clinical environment. Results: Data were collected from 245 patients. The average age was similar between the two groups (45.09 ± 12.12 years for sitting and 44.87 ± 11.09 years for lying down). The gender distribution was nearly equal, with a slightly higher number of females in both groups. Baseline FEV1 values were 1.85 ± 0.35 L for the sitting group and 1.88 ± 0.37 L for the lying down group, while baseline PEFR values were 300 ± 45 L/min and 310 ± 48 L/min, respectively. The study found that the mean change in PEFR was significantly greater in the sitting position group (+60 ± 15 L/min) compared to the lying down position group (+30 ± 12 L/min), with a difference of +30 L/min (95% CI: 18 to 42, p < 0.001). Conclusion: It is concluded that nebulizing asthmatic patients in a sitting position significantly improves expiratory flow rates compared to a lying down position.

Downloads

Download data is not yet available.

References

Kopack JK. Pulmonary Conditions and Treatment Interventions. Principles of Therapeutic Exercise for the Physical Therapist Assistant: Routledge; 2024. p. 623-43.

Bianco F, Salomone F, Milesi I, Murgia X, Bonelli S, Pasini E, et al. Aerosol drug delivery to spontaneously-breathing preterm neonates: lessons learned. Respiratory Research. 2021;22:1-31.

Ko H-Y. Respiratory Care and Intervention Strategies for Spinal Cord Injuries. A Practical Guide to Care of Spinal Cord Injuries: Clinical Questions and Answers: Springer; 2023. p. 483-518.

Reid WD, Chung F, Hill K. Answer Guides: Cases. Cardiopulmonary Physical Therapy: Routledge; 2024. p. 391-448.

Ko H-Y, Huh S, Ko H-Y, Huh S. Respiratory Dysfunction in Spinal Cord Injuries. Handbook of Spinal Cord Injuries and Related Disorders: A Guide to Evaluation and Management. 2021:341-66.

Muraro A, Worm M, Alviani C, Cardona V, DunnGalvin A, Garvey LH, et al. EAACI guidelines: Anaphylaxis (2021 update). Allergy. 2022;77(2):357-77.

Martins MP, Ortenzi AV, Perin D, Quintas G, Malito ML, Carvalho VH. Recommendations from the Brazilian Society of Anesthesiology (SBA) for difficult airway management in adults. Brazilian Journal of Anesthesiology. 2024;74:744477.

Farshadfar K, Sohooli M, Shekouhi R, Taherinya A, Qorbani M, Rezaei-Kojani M. The effects of nebulized ketamine and intravenous magnesium sulfate on corticosteroid resistant asthma exacerbation; a randomized clinical trial. Asthma Research and Practice. 2021;7:1-7.

Moody GB, Luckett PM, Shockley CM, Huang R, Ari A. Clinical efficacy of vibrating mesh and jet nebulizers with different interfaces in pediatric subjects with asthma. Respiratory care. 2020;65(10):1451-63.

Arunsurat I, Rittayamai N, Chuaychoo B, Tangchityongsiva S, Promsarn S, Yuenyong S, et al. Bronchodilator efficacy of high-flow nasal cannula in COPD: vibrating mesh nebulizer versus jet nebulizer. Respiratory Care. 2024;69(2):157-65.

Saeed H, Rabea H, Abdelwahab NS, Meabed MH, Abdelrahim ME. Effects of nebulizer fill volume on the efficacy and safety of the bronchodilator. Journal of Drug Delivery Science and Technology. 2020;56:101508.

Payares‐Salamanca L, Contreras‐Arrieta S, Florez‐García V, Barrios‐Sanjuanelo A, Stand‐Niño I, Rodriguez‐Martinez CE. Metered‐dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: A systematic review with meta‐analysis. Pediatric Pulmonology. 2020;55(12):3268-78.

Motamed H, Forouzan A, Masoumi K, Sajadi R. The effect of albuterol with heliox versus albuterol nebulization in acute asthma exacerbation: a randomized controlled clinical trial. Advances in Respiratory Medicine. 2022;90(1):86-93.

Chweich H, Idrees N, Rideout J, Barnewolt B, Rice L, Hill NS. Randomized Controlled Trial Assessing a Vibrating Mesh Nebulizer Compared to a Jet Nebulizer in Severe Asthma Exacerbations. Respiratory Care. 2024;69(3):345-8.

Hua J-l, Ye X-f, Du C-l, Xie N, Zhang J-q, Li M, et al. Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma. BMC Pulmonary Medicine. 2021;21:1-10.

Beuvon C, Coudroy R, Bardin J, Marjanovic N, Rault C, Bironneau V, et al. β Agonist delivery by high-flow nasal cannula during COPD exacerbation. Respiratory Care. 2022;67(1):9-15.

Almazroea Sr AH, Alharbi AH, Alawfi BA, Alsaedi BQ, Samman RS, Almohalwas MA. Does Good Nebulization Therapy in the Emergency Room Reduce the Need for Hospitalization in Asthmatic Children? Cureus. 2023;15(7).

Abedini A, Kiani A, Razavi F, Farahani M, Emami H, Valizadeh J, et al. Nebulized Budesonide and Formoterol in the Patients with Acute Asthma Exacerbation: A Randomized Clinical Trial Nebulized Budesonide and Formoterol in the Patients with Acute Asthma Exacerbation: A Randomized Clinical Trial Lized Budesonide and Formoterol in the Patients with Acute Asthma Exacerbation: A Randomized Clinical Trial. C61 ASTHMA: CLINICAL STUDIES: American Thoracic Society; 2020. p. A5628-A.